1. Dezaguanine mesylate: a new antipurine antimetabolite

   • W. R. Leopold
   • D. W. Fry
   • R. C. Jackson

   New Agent Review Pages: 223 - 231

2. Synergistic combination of menogarol and melphalan and other two drug combinations

   • B. K. Bhuyan
   • E. G. Adams
   • S. L. Crampton

   Preclinical Studies Pages: 233 - 244

3. Mitotic arrest and interphase inhibition induced by the pyrimidine sulfoxide NY 4138

   • E. O. Pettersen
   • O. Nome
   • R. Oftebro

   Preclinical Studies Pages: 245 - 253

4. Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine

   • Fred Valeriote
   • Ingomar D. Muntz
   • Teresa J. Vietti

   Preclinical Studies Pages: 255 - 261

5. Distribution, elimination, metabolism and bioavailability of hexamethylenebisacetamide in rats

   • Charles L. Litterst
   • Jeri S. Roth
   • James A. Kelley

   Preclinical Pharmacology Pages: 263 - 272

6. Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry

   • Ram Ganapathi
   • Peter Gulick
   • Ronald Bukowski

   Preclinical Pharmacology Pages: 273 - 277

7. Homoharringtonine: a phase I evaluation

   • James A. Stewart
   • Irwin H. Krakoff

   Phase I and II Clinical Trials Pages: 279 - 286

8. Phase I evaluation of intravenous difluoromethylornithine — a polyamine inhibitor

   • A. M. Maddox
   • M. J. Keating
   • E. J. Freireich

   Phase I and II Clinical Trials Pages: 287 - 292

9. Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysine

   • Uta Bruntsch
   • Günther Groos
   • Walter M. Gallmeier

   Phase I and II Clinical Trials Pages: 293 - 296

10. Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study

    • Robert H. Earhart
    • Franco M. Muggia
    • Frederick M. Golomb

    Phase I and II Clinical Trials Pages: 297 - 301

11. A phase II study of spirogermanium in patients with metastatic malignant melanoma

    • Elizabeth Eisenhauer
    • Ian Kerr
    • Ian Quirt

    Phase I and II Clinical Trials Pages: 303 - 305

12. A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma

    • Elizabeth Eisenhauer
    • Ian Quirt
    • Jamey Skillings

    Phase I and II Clinical Trials Pages: 307 - 310

13. Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck

    • Stephen D. Williams
    • Robert Birch
    • Richard Gams

    Phase I and II Clinical Trials Pages: 311 - 313

14. Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report

    • Werner Scheithauer
    • Heinz Ludwig
    • Eva Maida

    Case Report Pages: 315 - 318

15. Book review

    • Geoffrey R. Weiss

    BookReview Pages: 319 - 320